CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
CKD-aP or Something Else? Decoding the Diagnosis
Is CKD-aP Hiding in Your Dialysis Center?
Improving Sleep and Mental Health in Patients with CKD-aP
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Patrick Rossignol, MD, PhD
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Potassium Binders in Practice: Clinical Trial Evidence
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Meghan Sise, MD
Vladimir Tesar
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
Ahmad Masri, MD, MS
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD
Epilepsy: Beyond Seizure Impact
Optimizing VNS Parameters: Keys to Therapeutic Success